UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Humira permitted for nursing, pregnant patients
by Kim Yun-mi
2019-07-11 16:41
SCM Life Science, MitoImmune Therapeutics to develop new treatment
by Lee Han-soo
2019-07-11 16:40
Prosecutors raid 2 lead managers of Kolon TissueGene’s IPO
by Jeong Sae-im
2019-07-11 16:39
Acute renal failure reported in ibandronate injections
by Lee Hye-seon
2019-07-11 13:34
Rayence to market new detectors as GE brand
by Lee Han-soo
2019-07-11 12:47
라인
NKMax America seeks NASDAQ listing
by Jeong Sae-im
2019-07-11 12:41
Yuyu holds 3rd annual compliance program workshop
by Lee Han-soo
2019-07-11 12:09
Contera Pharma gets ₩3 billion funding from venture capital
by Jeong Sae-im
2019-07-10 17:28
Seoul Medical Center hands over public healthcare tips to Kyrgyzstan
by Song Soo-youn
2019-07-10 15:20
Psomagen seeks KOSDAQ listing using technology exception policy
by Jeong Sae-im
2019-07-10 15:20
라인
Court to test Nabota’s spore-forming to end Daewoong-Medytoxin dispute
by Jeong Sae-im
2019-07-10 12:44
'Teva's Fremanezumab improves migraine-related disorders, quality of life'
by Lee Han-soo
2019-07-09 16:57
‘Doctors know medical data best’
by Kim Eun-young
2019-07-09 16:07
ISU Abxis, Kyungpook National University to co-develop Alzheimer's disease treatment
by Lee Han-soo
2019-07-09 16:06
Sanofi Aventis names new general manager for consumer healthcare
by Lee Han-soo
2019-07-09 15:16
라인
GSK's Alitoc becoming salvation treatment for chronic hand eczema patients
by Lee Han-soo
2019-07-09 14:44
Kolon files administrative suit against Invossa license revocation
by Jeong Sae-im
2019-07-09 11:47
SillaJen shareholders panic over exec’s selling of 160,000 stocks
by Jeong Sae-im
2019-07-09 11:45
SNUH to transfer advanced clinical trial capability to Saudi Arabia
by Lee Han-soo
2019-07-08 16:44
61% of doctors oppose telemedicine; survey
by Song Soo-youn
2019-07-08 16:39
-
이전
111
112
113
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top